Video

Dr. Kris Discusses Tests Available for Lung Cancer

Dr. Kris from Memorial Sloan-Kettering Discusses Tests Available for Lung Cancer

Mark G. Kris, MD, the chief of Thoracic Oncology Service at Memorial Sloan-Kettering Cancer Center discusses tests available for lung cancer patients.

FISH is a poor cousin of mutation and that virtually all mutated patients are FISH positive. Tests for mutations are more potent predictors and most trials use them. Some of the tests are done by FISH test. They look for MET amplifications and EML4-ALK as a FISH test.

Dr. Kris says the vast majority of tests are for mutations. He says

Related Videos
Byoung Chol Cho, MD, PhD, professor, internal medicine, Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine
Stephen J. Freedland, MD
Ben Levy, MD, and Yan Leyfman, MD
Viktor Grünwald, MD, PhD
Aaron Gerds, MD
BDTX-1535 – A MasterKey EGFR Inhibitor Targeting Classical, Non-Classical, and the C797S Resistance Mutation To Address The Evolved Landscape Of EGFR Mutant NSCLC
Christine M. Lovly, MD, PhD, Ingram Associate Professor of Cancer Research, associate professor, medicine (hematology/oncology), Vanderbilt-Ingram Cancer Center
Haeseong Park, MD, MPH
David L. Porter, MD
Timothy Yap, MBBS, PhD, FRCP